Was Jim Cramer Right About These 23 Stocks?

3. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Holders: 72

When Teva Pharmaceutical Industries Limited (NYSE:TEVA) was mentioned by a caller on the show, Cramer admitted that he has been hard on the stock, saying:

“You’re right. I’ve been hard on Teva because I like Lilly, but Teva’s situation is improving and it’s ridiculously inexpensive. And they actually got some good scientists there! So I’m not knocking Teva anymore.”

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has risen by 19.36% since those comments.

For Cramer, the firm’s under-development drug for ulcerative colitis and Crohn’s disease is all the hype as he commented the following on the 17^th of December 2024:

“[ULCERATIVE COLITIS AND CROHN’S] people have had some struggles with it, there are drugs out there that right now, they are so expensive, this would be a major break in inflation in the system. And they’re going right to three, and I thought it was very encouraging.”